Chan et al. showed that regular use of aspirin after a CRC diagnosis is associated with a lower risk of colorectal cancer-specific and overall mortality, especially for individuals with tumors that overexpress COX-2 [180]. Here, PTGS2 is linked to colorectal carcinoma.